A Natural History Study of Transthyretin (ATTR) Amyloidosis: Trends in Overall Survival at a U.S. Referral Center PC65 (#373)
Andrew Staron(Boston University), Vaishali Sanchorawala(Boston Medical Center), Tatiana Prokaeva(Boston University), A Deandrea, Lisa Mendelson(Boston University), L John, James Signorovitch(Analysis Group (United States)), Tracy Joshi(Boston University), Jessica Smith(University of Florida), Alexandra Greatsinger(Analysis Group (United States)), Natasha Burke(Boston University), Nadia Tabatabaeepour(Analysis Group (United States)), M. Deepa, Brian Spencer(Boston University), K.O. Omar, Frederick L. Ruberg(Boston University)
Cited by 0
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
|Circulation|2018|837
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
|Circulation Heart Failure|2019|560